Lexicon Pharmaceuticals LXRX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's other noncash income (expense)?
- Lexicon Pharmaceuticals (LXRX) reported other noncash income (expense) of $581K in Q1 2026.
- How has Lexicon Pharmaceuticals's other noncash income (expense) changed year-over-year?
- Lexicon Pharmaceuticals's other noncash income (expense) decreased by 62.3% year-over-year, from $1.54M to $581K.
- What is the long-term trend for Lexicon Pharmaceuticals's other noncash income (expense)?
- Over 2 years (2023 to 2025), Lexicon Pharmaceuticals's other noncash income (expense) has grown at a 7.3% compound annual growth rate (CAGR), from -$1.51M to $1.74M.